RxDoctor Payments DataLook up a doctor →

Kristi Mizelle, MD

Rheumatology · Newport News, VANPI 1457490955

Payments from drug & device makers

$1,231,325in general payments, 2019–2025

Across 1,869 payments — averaging $658.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$332K
  • Lilly USA, LLC$229K
  • Amgen$223K
  • GSK$125K
  • Johnson & Johnson$104K
  • Pfizer$39K
  • plus $179K from 36 others
$6,030in research payments, 2019–2025

Across 5 payments — averaging $1206.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$6K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,231,325 in reported general payments places this provider in the 95th percentile of 159 rheumatology providers in Virginia.

See all rheumatology providers in Virginia

Medicare billing

Part B allowed, 2024
$3,695,820
Medicare patients
1,069
Services billed
180,280

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other rheumatology in Newport News

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →